American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
74 hedge funds and large institutions have $296M invested in American Oncology Network, Inc. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
55% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 11
10% more capital invested
Capital invested by funds: $269M → $296M (+$27.2M)
4% more funds holding
Funds holding: 71 → 74 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$11M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
+$6.14M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$5.4M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$5.05M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$2.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$7.38M |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$5.38M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.47M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.29M |
| 5 |
PCM
Prelude Capital Management
New York
|
-$570K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECP
76
Empyrean Capital Partners
Los Angeles,
California
| – | -$5.38M | -550,000 | Closed |
|
|
AC
77
Antara Capital
New York
| – | -$189K | -19,300 | Closed |
|
78
Bank of America
Charlotte,
North Carolina
| – | -$98K | -10,000 | Closed |
|
AONC Hedge Fund Activity: Q3 2022 in Review
74 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q3 2022, worth a combined $296M — up 10% from $269M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AONC positions and 4 closed out — a net gain of 3 holders — while 17 added to existing stakes and 11 trimmed.
The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $11M. The largest seller was Goldman Sachs, exiting entirely with an estimated $7.38M sold.
- 74 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q3 2022, up from 71 in Q2 2022.
- Funds reported $296M of American Oncology Network, Inc. Class A Common Stock stock for Q3 2022, up 10% quarter-over-quarter.
- 7 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q3 2022 and 4 closed out, a net change of +3 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $11M added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q3 2022 was Goldman Sachs, an estimated $7.38M sold.
Based on aggregated 13F filings for Q3 2022.